BioStem Technologies, Inc.
BSEM
$4.20
-$0.39-8.50%
OTC PK
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 09/30/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | 884.58% | 3,443.55% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | 884.58% | 3,443.55% |
| Cost of Revenue | -- | -- | -- | 1,333.70% | 1,333.70% |
| Gross Profit | -- | -- | -- | 818.93% | 3,752.00% |
| SG&A Expenses | -- | -- | -- | 71.20% | 1,079.61% |
| Depreciation & Amortization | -- | -- | -- | -8.06% | -6.33% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -- | -- | -- | 131.10% | 1,058.90% |
| Operating Income | -- | -- | -- | 297.47% | 297.47% |
| Income Before Tax | -- | -- | -- | 265.65% | 265.65% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -- | -- | -- | 215.99% | 216.00% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -- | -- | -- | 216.48% | 216.48% |
| EBIT | -- | -- | -- | 297.47% | 297.47% |
| EBITDA | -- | -- | -- | 303.92% | 303.96% |
| EPS Basic | -- | -- | -- | 192.29% | 192.29% |
| Normalized Basic EPS | -- | -- | -- | 246.85% | 246.85% |
| EPS Diluted | -- | -- | -- | 167.03% | 168.02% |
| Normalized Diluted EPS | -- | -- | -- | 210.47% | 212.57% |
| Average Basic Shares Outstanding | -- | -- | -- | 21.60% | 21.60% |
| Average Diluted Shares Outstanding | -- | -- | -- | 46.96% | 45.17% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |